ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $688,432,000 | +82.9% | 4,476,100 | +49.2% | 10.82% | +65.1% |
Q2 2021 | $376,470,000 | -7.5% | 3,000,000 | 0.0% | 6.55% | -6.8% |
Q1 2021 | $406,830,000 | +105.2% | 3,000,000 | +93.5% | 7.03% | +105.7% |
Q4 2020 | $198,307,000 | +30.5% | 1,550,000 | +14.8% | 3.42% | +58.2% |
Q3 2020 | $151,916,000 | +53.3% | 1,350,000 | +29.8% | 2.16% | +10.2% |
Q2 2020 | $99,081,000 | +28.2% | 1,040,000 | +20.9% | 1.96% | -24.9% |
Q1 2020 | $77,288,000 | – | 860,000 | – | 2.61% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
RA Capital Management | 318,565 | $11,529,000 | 1.19% |
OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
QVT Financial LP | 636,764 | $23,044,000 | 0.87% |